伽玛刀放射外科治疗葡萄膜黑色素瘤与转移瘤的系统综述与荟萃分析
该系统综述与荟萃分析检索MEDLINE和Embase(1960年9月至2020年2月),纳入52项研究共1010例葡萄膜黑色素瘤和34例眼内转移瘤患者,其中28项研究进入荟萃分析。I2=83%)出现肿瘤消退。伽玛刀放射外科是治疗葡萄膜黑色素瘤和眼内转移瘤的有效主要方法,肿瘤控制率可靠,但需随机对照试验进一步评估安全性和疗效。
要点
- 需随机对照试验进一步评估该治疗的安全性和疗效。
核心结论
- 伽玛刀放射外科是治疗葡萄膜黑色素瘤和眼内转移瘤的有效主要方法,肿瘤控制率可靠。
研究设计与样本
- 系统综述与荟萃分析,检索MEDLINE和Embase(1960年9月1日至2020年2月1日)的英文临床研究及灰色文献。
- 52项研究(1010例葡萄膜黑色素瘤和34例眼内转移瘤)纳入系统综述,其中28项研究进入荟萃分析。
- 采用DerSimonian-Laird随机效应模型合并比例,并进行Freeman-Tukey双反正弦转换。
临床怎么用
- 伽玛刀放射外科可作为葡萄膜黑色素瘤和眼内转移瘤的主要治疗选择之一。
局限性
- 纳入研究为临床研究及灰色文献,非随机对照试验,可能存在异质性和偏倚。
- 肿瘤消退结局的异质性较高(I2=83%)。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Gamma knife radiosurgery is regarded as the gold-standard stereotactic radiosurgery modality for the treatment of intracranial tumours, and its use has been expanded for the treatment of intraocular malignancies. The aim of this study was to systematically evaluate the efficacy, outcomes, and complications of gamma knife radiosurgery for uveal melanomas and metastases. METHODS: We did a systematic review and meta-analysis to aggregate the clinical outcomes of patients with uveal melanomas or intraocular metastases treated primarily with gamma knife radiosurgery. We searched MEDLINE and Embase for studies published between Sept 1, 1960, and Feb 1, 2020, reporting the use of gamma knife radiosurgery as primary treatment for uveal melanoma or uveal metastases. The search was restricted to clinical studies and relevant grey literature published in English. Studies reporting treatment of benign tumours, extraocular tumours, or other forms of stereotactic radiosurgery were excluded to reduce heterogeneity. No restrictions were placed on participant criteria. Local tumour control and tumour regression were extracted as the primary outcomes and analysed via a random-effects meta-analysis of proportions using the DerSimonian and Laird method with a Freeman-Tukey double arcsine transformation. This study is registered with PROSPERO, CRD42019148165. FINDINGS: Our search returned 454 studies, of which 109 were assessed for full-text eligibility. 52 studies, reporting on 1010 patients with uveal melanoma and 34 intraocular metastases, were eligible for systematic review. 28 studies were included in the meta-analysis. 840 of 898 patients (0·96, 95% CI 0·94-0·97; I2=16%) from 19 studies had local control, and 378 of 478 patients (0·81, 0·70-0·90; I2=83%) from 16 studies experienced tumour regression. INTERPRETATION: Gamma knife radiosurgery is an efficacious primary method of treating uveal melanomas and intraocular metastases, with reliable tumour control rates. Randomised controlled trials should further evaluate the safety and efficacy of gamma knife radiosurgery in this setting. FUNDING: The Rhodes Trust and the Howard Brain Sciences Foundation.
引用
- Parker T, Rigney G, Kallos J, et al. Gamma knife radiosurgery for uveal melanomas and metastases: a systematic review and meta-analysis. Lancet Oncol. 2020. PMID: 33152286. doi:10.1016/S1470-2045(20)30459-9
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。